ASX Announcement PERCHERON AND INVION TO EXPLORE NOVEL COMBINATION OF VISTA IMMUNOTHERAPY AND PHOTOSOFT™ FOR CANCER • Percheron Therapeutics and Invion to undertake preclinical studies evaluating HMBD-002, a VISTA targeting immune checkpoint inhibitor (ICI), in combination with Invion’s...